182 results on '"Stepanova, María"'
Search Results
2. Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region
3. The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
4. The use of a psychiatric overflow unit in a large urban community hospital to improve process outcomes
5. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease
6. SERS probing of fungal HET-s fibrils formed at neutral and acidic pH conditions
7. Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease
8. Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease
9. The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States
10. The Potential Role of Fatigue in Identifying Patients With NASH and Advanced Fibrosis Who Experience Disease Progression
11. Photoluminescence emission in arsenic sulfide nanocomposite
12. Self-regulation Management in IoT Infrastructure Using Machine Learning
13. Universal Multi-platform Interaction Approach for Distributed Internet of Things
14. The Impact of NASH to Liver Transplantations With Hepatocellular Carcinoma in the United States
15. Significance of native PLGA nanoparticles in the treatment of Alzheimer's disease pathology
16. Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry
17. Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis
18. Hepatic Fat Reduction Due to Resmetirom in Patients With Nonalcoholic Steatohepatitis Is Associated With Improvement of Quality of Life
19. A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease
20. Serum Biomarkers are Associated With Atherosclerotic Cardiovascular Disease Among Patients With Nonalcoholic Fatty Liver Disease Undergoing Elective Angiography
21. Prion protein with a mutant N-terminal octarepeat region undergoes cobalamin-dependent assembly into high–molecular weight complexes
22. Health-Related Quality of Life and Health Care Resource Utilization in Patients With Chronic Liver Disease and Primary Liver Cancer in the United States: Analysis of Medical Expenditure Panel Survey
23. Development of Organizational Diagrams and Governance Mechanisms of Region’s Economy
24. A Reinforcement Learning Approach for Task Assignment in IoT Distributed Platform
25. Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response
26. Transformation of the Industrial Potential in the Digital Economy
27. The State and Development of the Real Estate Market
28. Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B
29. Health-related quality of life in Cuban patients with chronic liver disease: A real-world experience
30. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States
31. The Main Tendencies and Directions of State Policy in the Sphere of Technological Development of Russia
32. Long-term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus Infection
33. Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis
34. Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis
35. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease
36. Unusual van Deemter plots of optical isomers on a chiral brush-type liquid chromatography column
37. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
38. The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options
39. Hepatitis C in Patients With Minimal or No Hepatic Fibrosis : The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes
40. Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study
41. Hepatitis C Virus–Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free Regimens
42. French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported Outcomes
43. Effects of Treatment of Chronic Hepatitis B Virus Infection on Patient-Reported Outcomes
44. Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV)
45. Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir
46. Economic Burden of Hepatitis C Infection
47. Direct and Indirect Economic Burden of Chronic Liver Disease in the United States
48. Survival Analysis Methods for Personal Loan Data
49. Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis
50. Fundamentals of Electron Beam Exposure and Development
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.